<b>Industry Reports</b><br> &#183 IRBs: Facing a Crackdown<br> &#183 Another Setback for CROs: Strained Relations with Euro Sites<br> &#183 Month in Review<br> &#183 Letter to the Editor<br> <b>CentreStage Europe</b><br> &#183 Common Time Frames for U.S. and European Drug Approval<br> <b>Grant Opportunities</b><br> &#183 Eye on Leukemia<br> &#183 Trial Watch<br> &#183 Opportunities Underway<br> <b>Publisher's Letter</b>